NCBI Home Page NCBI Site Search page NCBI Guide that lists and describes the NCBI resources
Conserved domains on  [gi|1034671665|ref|XP_016870720|]
View 

aminopeptidase O isoform X6 [Homo sapiens]

Protein Classification

M1 family metallopeptidase( domain architecture ID 10329665)

M1 family metallopeptidase is a zinc-dependent metallopeptidase that functions as an aminopeptidase and contains an HEXXH motif as part of its active site; such as aminopeptidase B that selectively removes arginine and/or lysine residues from the N-terminus of peptide substrates

Graphical summary

 Zoom to residue level

show extra options »

Show site features     Horizontal zoom: ×

List of domain hits

Name Accession Description Interval E-value
Leuk-A4-hydro_C pfam09127
Leukotriene A4 hydrolase, C-terminal; Members of this family adopt a structure consisting of ...
622-719 3.41e-22

Leukotriene A4 hydrolase, C-terminal; Members of this family adopt a structure consisting of two layers of parallel alpha-helices, five in the inner layer and four in the outer, arranged in an antiparallel manner, with perpendicular loops containing short helical segments on top. They are required for the formation of a deep cleft harbouring the catalytic Zn2+ site in Leukotriene A4 hydrolase.


:

Pssm-ID: 462686  Cd Length: 112  Bit Score: 92.17  E-value: 3.41e-22
                          10        20        30        40        50        60        70        80
                  ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1034671665 622 QKTLSPRTLQSLQRTYHLQD-QDAEVRHRWCELIVKHKFTKAYKSVERFLQE--DQAMGVYLYGELMVSEdarqQQLARR 698
Cdd:pfam09127  16 FSPLSPEQLKALDEVYKLSEsKNAEIRFRWLRLALKAKYEPAYPEVAEFLGEvgRMKFVRPLYRALNKVD----RDLAVE 91
                          90       100
                  ....*....|....*....|.
gi 1034671665 699 CFERTKEQMDRSSAQVVAEML 719
Cdd:pfam09127  92 TFEKNKDFYHPICRAMVEKDL 112
GluZincin super family cl14813
Gluzincin Peptidase family (thermolysin-like proteinases, TLPs) which includes peptidases M1, ...
244-553 5.74e-21

Gluzincin Peptidase family (thermolysin-like proteinases, TLPs) which includes peptidases M1, M2, M3, M4, M13, M32 and M36 (fungalysins); The Gluzincin family (thermolysin-like peptidases or TLPs) includes several zinc-dependent metallopeptidases such as M1, M2, M3, M4, M13, M32, M36 peptidases (MEROPS classification), which contain the HEXXH motif as part of their active site. Peptidases in this family bind a single catalytic zinc ion which is tetrahedrally co-ordinated by three amino acid ligands and a water molecule that forms the nucleophile on activation during catalysis. The M1 family includes aminopeptidase N (APN) and leukotriene A4 hydrolase (LTA4H). APN preferentially cleaves neutral amino acids from the N-terminus of oligopeptides and is present in a variety of human tissues and cell types. LTA4H is a bifunctional enzyme, possessing an aminopeptidase as well as an epoxide hydrolase activity such that the two activities occupy different, but overlapping sites. The M3_like peptidases include the M2_ACE, M3 or neurolysin-like family (subfamilies M3B_PepF and M3A) and M32_Taq peptidases. The M2 peptidase angiotensin converting enzyme (ACE, EC 3.4.15.1) catalyzes the conversion of decapeptide angiotensin I to the potent vasopressor octapeptide angiotensin II. ACE is a key component of the renin-angiotensin system that regulates blood pressure, thus ACE inhibitors are important for the treatment of hypertension. M3A includes thimet oligopeptidase (TOP; endopeptidase 3.4.24.15), neurolysin (3.4.24.16), and the mitochondrial intermediate peptidase; and M3B includes oligopeptidase F. The M32 family includes eukaryotic enzymes from protozoa Trypanosoma cruzi, a causative agent of Chagas' disease, and from Leishmania major, a parasite that causes leishmaniasis, making these enzymes attractive targets for drug development. The M4 family includes secreted protease thermolysin (EC 3.4.24.27), pseudolysin, aureolysin, and neutral protease as well as bacillolysin (EC 3.4.24.28) that degrade extracellular proteins and peptides for bacterial nutrition, especially prior to sporulation. Thermolysin is widely used as a nonspecific protease to obtain fragments for peptide sequencing as well as in production of the artificial sweetener aspartame. The M13 family includes neprilysin (EC 3.4.24.11) and endothelin-converting enzyme I (ECE-1, EC 3.4.24.71), which fulfill a broad range of physiological roles due to the greater variation in the S2' subsite allowing substrate specificity and are prime therapeutic targets for selective inhibition. The peptidase M36 fungalysin family includes endopeptidases from pathogenic fungi. Fungalysin hydrolyzes extracellular matrix proteins such as elastin and keratin. Aspergillus fumigatus causes the pulmonary disease aspergillosis by invading the lungs of immuno-compromised animals and secreting fungalysin that possibly breaks down proteinaceous structural barriers.


The actual alignment was detected with superfamily member cd09599:

Pssm-ID: 472708 [Multi-domain]  Cd Length: 442  Bit Score: 96.37  E-value: 5.74e-21
                          10        20        30        40        50        60        70        80
                  ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1034671665 244 IRIWYKTKPEGRSVTW-----TSDQSgRPCVYTVGSPINNRALFPCQEPPVAMSTWQATVRAAASFVVLMSGENSAKPtq 318
Cdd:cd09599    98 VKIEYSTTPQATALQWltpeqTAGKK-HPYLFTQCQAIHARSLFPCQDTPSVKSTYSATVTVPKGLTALMSALRTGEK-- 174
                          90       100       110       120       130       140       150       160
                  ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1034671665 319 lwEECSSWYYYVTM--PMPASTFTIAVGcwtemkmetwssnDLAtERPFSPseanfrHVGVCShmEypcrfqnasattqe 396
Cdd:cd09599   175 --EEAGTGTYTFEQpvPIPSYLIAIAVG-------------DLE-SREIGP------RSGVWA--E-------------- 216
                         170       180       190       200       210       220       230       240
                  ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1034671665 397 iiPHRVfapvcltgACQETLLRLIPPCLSAAHSVLGAHPFSRLDVLIVPANFPSLGMARP----------SKDKtghtsd 466
Cdd:cd09599   217 --PSVV--------DAAAEEFADTEKFLKAAEKLYGPYVWGRYDLLVLPPSFPYGGMENPcltfatptliAGDR------ 280
                         250       260       270       280       290       300       310       320
                  ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1034671665 467 SGASVIKH------------------------------------------------------------------------ 474
Cdd:cd09599   281 SLVDVIAHeiahswsgnlvtnanwehfwlnegftvylerrilerlygeeyrqfeailgwkdlqesikefgedppytllvp 360
                         330       340       350       360       370       380       390       400
                  ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1034671665 475 ---GLNPEKIFMQVHYLKGYFLLRFLAKRLGDETYFSFLRKFVHTFHGQLILSQDFLQMLLENIPEEKRLELSVENIyQD 551
Cdd:cd09599   361 dlkGVDPDDAFSSVPYEKGFQFLYYLEQLGGREVFDPFLRAYFKKFAFQSIDTEDFKDFLLEYFAEDKPEILDKIDW-DA 439

                  ..
gi 1034671665 552 WL 553
Cdd:cd09599   440 WL 441
 
Name Accession Description Interval E-value
Leuk-A4-hydro_C pfam09127
Leukotriene A4 hydrolase, C-terminal; Members of this family adopt a structure consisting of ...
622-719 3.41e-22

Leukotriene A4 hydrolase, C-terminal; Members of this family adopt a structure consisting of two layers of parallel alpha-helices, five in the inner layer and four in the outer, arranged in an antiparallel manner, with perpendicular loops containing short helical segments on top. They are required for the formation of a deep cleft harbouring the catalytic Zn2+ site in Leukotriene A4 hydrolase.


Pssm-ID: 462686  Cd Length: 112  Bit Score: 92.17  E-value: 3.41e-22
                          10        20        30        40        50        60        70        80
                  ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1034671665 622 QKTLSPRTLQSLQRTYHLQD-QDAEVRHRWCELIVKHKFTKAYKSVERFLQE--DQAMGVYLYGELMVSEdarqQQLARR 698
Cdd:pfam09127  16 FSPLSPEQLKALDEVYKLSEsKNAEIRFRWLRLALKAKYEPAYPEVAEFLGEvgRMKFVRPLYRALNKVD----RDLAVE 91
                          90       100
                  ....*....|....*....|.
gi 1034671665 699 CFERTKEQMDRSSAQVVAEML 719
Cdd:pfam09127  92 TFEKNKDFYHPICRAMVEKDL 112
M1_LTA4H cd09599
Peptidase M1 family including Leukotriene A4 hydrolase catalytic domain; This model represents ...
244-553 5.74e-21

Peptidase M1 family including Leukotriene A4 hydrolase catalytic domain; This model represents the N-terminal catalytic domain of leukotriene A4 hydrolase (LTA4H; E.C. 3.3.2.6) and the close homolog cold-active aminopeptidase (Colwellia psychrerythraea-type peptidase; ColAP), both members of the aminopeptidase M1 family. LTA4H is a bifunctional enzyme, possessing an aminopeptidase as well as an epoxide hydrolase activity. The two activities occupy different, but overlapping sites. The activity and physiological relevance of the aminopeptidase is poorly understood while the epoxide hydrolase converts leukotriene A4 (LTA4) into leukotriene B4 (LTB4), a potent chemotaxin that is fundamental to the inflammatory response of mammals. It accepts a variety of substrates, including some opioid, di- and tripeptides, as well as chromogenic aminoacyl-p-nitroanilide derivatives. The aminopeptidase activity of LTA4H is possibly involved in the processing of peptides related to inflammation and host defense. Kinetic analysis shows that LTA4H hydrolyzes arginyl tripeptides with high efficiency and specificity, indicating its function as an arginyl aminopeptidase. Thermodynamic characterization using different biophysical methods shows that structurally distinct inhibitors of the LTA4H occupy different regions of the binding site; while some (RB202, ARM1 and SC57461A) bind to the hydrophobic hydrolase side, both bestatin and captopril are located at the hydrophilic peptidase side. LTB4H overexpression is associated with different pathological conditions and diseases such as cystic fibrosis, coronary heart disease, sepsis, shock, connective tissue disease, and chronic obstructive pulmonary disease. It is also overexpressed in certain human cancers, and has been identified as a functionally important target for mediating anticancer properties of resveratrol, a well-known red wine polyphenolic compound with cancer chemopreventive activity.


Pssm-ID: 341062 [Multi-domain]  Cd Length: 442  Bit Score: 96.37  E-value: 5.74e-21
                          10        20        30        40        50        60        70        80
                  ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1034671665 244 IRIWYKTKPEGRSVTW-----TSDQSgRPCVYTVGSPINNRALFPCQEPPVAMSTWQATVRAAASFVVLMSGENSAKPtq 318
Cdd:cd09599    98 VKIEYSTTPQATALQWltpeqTAGKK-HPYLFTQCQAIHARSLFPCQDTPSVKSTYSATVTVPKGLTALMSALRTGEK-- 174
                          90       100       110       120       130       140       150       160
                  ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1034671665 319 lwEECSSWYYYVTM--PMPASTFTIAVGcwtemkmetwssnDLAtERPFSPseanfrHVGVCShmEypcrfqnasattqe 396
Cdd:cd09599   175 --EEAGTGTYTFEQpvPIPSYLIAIAVG-------------DLE-SREIGP------RSGVWA--E-------------- 216
                         170       180       190       200       210       220       230       240
                  ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1034671665 397 iiPHRVfapvcltgACQETLLRLIPPCLSAAHSVLGAHPFSRLDVLIVPANFPSLGMARP----------SKDKtghtsd 466
Cdd:cd09599   217 --PSVV--------DAAAEEFADTEKFLKAAEKLYGPYVWGRYDLLVLPPSFPYGGMENPcltfatptliAGDR------ 280
                         250       260       270       280       290       300       310       320
                  ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1034671665 467 SGASVIKH------------------------------------------------------------------------ 474
Cdd:cd09599   281 SLVDVIAHeiahswsgnlvtnanwehfwlnegftvylerrilerlygeeyrqfeailgwkdlqesikefgedppytllvp 360
                         330       340       350       360       370       380       390       400
                  ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1034671665 475 ---GLNPEKIFMQVHYLKGYFLLRFLAKRLGDETYFSFLRKFVHTFHGQLILSQDFLQMLLENIPEEKRLELSVENIyQD 551
Cdd:cd09599   361 dlkGVDPDDAFSSVPYEKGFQFLYYLEQLGGREVFDPFLRAYFKKFAFQSIDTEDFKDFLLEYFAEDKPEILDKIDW-DA 439

                  ..
gi 1034671665 552 WL 553
Cdd:cd09599   440 WL 441
PepN COG0308
Aminopeptidase N, contains DUF3458 domain [Amino acid transport and metabolism];
217-560 1.70e-14

Aminopeptidase N, contains DUF3458 domain [Amino acid transport and metabolism];


Pssm-ID: 440077 [Multi-domain]  Cd Length: 609  Bit Score: 76.99  E-value: 1.70e-14
                          10        20        30        40        50        60        70        80
                  ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1034671665 217 ELLFDTDTWSLQIRKTGAQTATDfPHAIRIWYKTKPEGRSVTW---TSDQSGRPCVYTVGSPINNRALFPCQEPPVAMST 293
Cdd:COG0308    69 PLDFTRDGERLTITLPKPLAPGE-TFTLEIEYSGKPSNGGEGLyrsGDPPDGPPYLYTQCEPEGARRWFPCFDHPDDKAT 147
                          90       100       110       120       130       140       150       160
                  ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1034671665 294 WQATVRAAASFVVLMSGeNSAKPTQLWEECSSWYYYVTMPMPASTFTIAVGcwtemkmetwssndlaterpfspseanfr 373
Cdd:COG0308   148 FTLTVTVPAGWVAVSNG-NLVSETELGDGRTTWHWADTQPIPTYLFALAAG----------------------------- 197
                         170       180       190       200       210       220       230       240
                  ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1034671665 374 hvgvcshmeypcRFQNASATTQEIIPHRVFAPVCLTGACQETLLRLiPPCLSAAHSVLG-AHPFSRLDVLIVPaNFPSLG 452
Cdd:COG0308   198 ------------DYAVVEDTFASGVPLRVYVRPGLADKAKEAFEST-KRMLDFFEELFGvPYPFDKYDQVAVP-DFNFGA 263
                         250       260       270       280       290       300       310       320
                  ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1034671665 453 M-------------ARP-------------------------------------------------SKDKTGHT------ 464
Cdd:COG0308   264 MenqglvtfgekvlADEtatdadyerresviahelahqwfgnlvtcadwddlwlnegfatymeqlfSEDLYGKDaadrif 343
                         330       340       350       360       370       380       390       400
                  ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1034671665 465 ----------SDSGAS----VIKHGLNPEKIFMQVHYLKGYFLLRFLAKRLGDETYFSFLRKFVHTFHGQLILSQDFLQM 530
Cdd:COG0308   344 vgalrsyafaEDAGPNahpiRPDDYPEIENFFDGIVYEKGALVLHMLRTLLGDEAFRAGLRLYFARHAGGNATTEDFLAA 423
                         410       420       430
                  ....*....|....*....|....*....|
gi 1034671665 531 LlenipeEKRLELSVENIYQDWLESSGIPK 560
Cdd:COG0308   424 L------EEASGRDLSAFFDQWLYQAGLPT 447
leuko_A4_hydro TIGR02411
leukotriene A-4 hydrolase/aminopeptidase; Members of this family represent a distinctive ...
244-707 4.06e-11

leukotriene A-4 hydrolase/aminopeptidase; Members of this family represent a distinctive subset within the zinc metallopeptidase family M1 (pfam01433). The majority of the members of pfam01433 are aminopeptidases, but the sequences in this family for which the function is known are leukotriene A-4 hydrolase. A dual epoxide hydrolase and aminopeptidase activity at the same active site is indicated. The physiological substrate for aminopeptidase activity is not known.


Pssm-ID: 274120 [Multi-domain]  Cd Length: 602  Bit Score: 66.34  E-value: 4.06e-11
                          10        20        30        40        50        60        70        80
                  ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1034671665 244 IRIWYKTKPEGRSVTW-TSDQ-SGR--PCVYTVGSPINNRALFPCQEPPVAMSTWQATVRaaASFVVLMSGENSAKPTql 319
Cdd:TIGR02411  97 LNISFSTTPKCTALQWlNPEQtSGKkhPYLFSQCQAIHARSLFPCQDTPSVKSTYTAEVE--SPLPVLMSGIRDGETS-- 172
                          90       100       110       120       130       140       150       160
                  ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1034671665 320 wEECSSWYYYVTMPMPASTFTIAVGcwtemkmetwssnDLATeRPFSPseanfrhvgvcshmeypcrfqNASATTQEIIP 399
Cdd:TIGR02411 173 -NDPGKYLFKQKVPIPAYLIAIASG-------------DLAS-APIGP---------------------RSTVYSEPEQL 216
                         170       180       190       200       210       220       230       240
                  ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1034671665 400 HrvfapvcltgACQETLLRLIPPCLSAAHSVLGAHPFSRLDVLIVPANFPSLGMARP----------SKDKtghtsdSGA 469
Cdd:TIGR02411 217 E----------KCQYEFENDTEKFIKTAEDLIFPYEWGQYDLLVLPPSFPYGGMENPnltfatptliAGDR------SNV 280
                         250       260       270       280       290       300       310       320
                  ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1034671665 470 SVIKHGL------------------------------------------------------------------------- 476
Cdd:TIGR02411 281 DVIAHELahswsgnlvtncswehfwlnegwtvylerriigrlygektrhfsaligwgdlqesvktlgetpeftklvvdlk 360
                         330       340       350       360       370       380       390       400
                  ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1034671665 477 --NPEKIFMQVHYLKGYFLLRFLAKRLGDETYFS-FLRKFVHTFHGQLILSQDFLQMLLENIPEEKRLELSVENIYQDWL 553
Cdd:TIGR02411 361 dnDPDDAFSSVPYEKGFNFLFYLEQLLGGPAEFDpFLRHYFKKFAYKSLDTYQFKDALYEYFKDKKKVDKLDAVDWETWL 440
                         410       420       430       440       450       460       470       480
                  ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1034671665 554 ESSGIP--KPlqrerraGAECGLARQVRAEVTKWIGVNRRPRKRK-RREKEEVFEKLLPDQLVLLLEHLLEQKTLSPRTL 630
Cdd:TIGR02411 441 YSPGMPpvKP-------NFDTTLADECYALADRWVDAAKADDLSSfNAKDIKDFSSHQLVLFLETLTERGGDWALPEGHI 513
                         490       500       510       520       530       540       550       560
                  ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1034671665 631 QSLQRTYHL-QDQDAEVRHRWCELIVKHKFTKAYKSVERFLQEDQAMGVY--LYGELMVSEDARQqqlARRCFERTKEQM 707
Cdd:TIGR02411 514 KRLGDIYNFaASKNAEVRFRWFRLAIQAKLEDEYPLLADWLGTVGRMKFVrpGYRLLNAFVDRDL---AIRTFEKFKDSY 590
Peptidase_M1 pfam01433
Peptidase family M1 domain; Members of this family are aminopeptidases. The members differ ...
450-533 3.76e-04

Peptidase family M1 domain; Members of this family are aminopeptidases. The members differ widely in specificity, hydrolysing acidic, basic or neutral N-terminal residues. This family includes leukotriene-A4 hydrolase, this enzyme also has an aminopeptidase activity.


Pssm-ID: 426262 [Multi-domain]  Cd Length: 219  Bit Score: 42.66  E-value: 3.76e-04
                          10        20        30        40        50        60        70        80
                  ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1034671665 450 SLGMARPSKDKTGHTSDsgasvikhglnPEKIFMQVHYLKGYFLLRFLAKRLGDETYFSFLRKFVHTFHGQLILSQDFLQ 529
Cdd:pfam01433 133 ALDSSHPITQNVNDPSE-----------IDDIFDAIPYEKGASVLRMLETLLGEEVFQKGLRSYLKKFQYGNATTEDLWD 201

                  ....
gi 1034671665 530 MLLE 533
Cdd:pfam01433 202 ALSE 205
 
Name Accession Description Interval E-value
Leuk-A4-hydro_C pfam09127
Leukotriene A4 hydrolase, C-terminal; Members of this family adopt a structure consisting of ...
622-719 3.41e-22

Leukotriene A4 hydrolase, C-terminal; Members of this family adopt a structure consisting of two layers of parallel alpha-helices, five in the inner layer and four in the outer, arranged in an antiparallel manner, with perpendicular loops containing short helical segments on top. They are required for the formation of a deep cleft harbouring the catalytic Zn2+ site in Leukotriene A4 hydrolase.


Pssm-ID: 462686  Cd Length: 112  Bit Score: 92.17  E-value: 3.41e-22
                          10        20        30        40        50        60        70        80
                  ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1034671665 622 QKTLSPRTLQSLQRTYHLQD-QDAEVRHRWCELIVKHKFTKAYKSVERFLQE--DQAMGVYLYGELMVSEdarqQQLARR 698
Cdd:pfam09127  16 FSPLSPEQLKALDEVYKLSEsKNAEIRFRWLRLALKAKYEPAYPEVAEFLGEvgRMKFVRPLYRALNKVD----RDLAVE 91
                          90       100
                  ....*....|....*....|.
gi 1034671665 699 CFERTKEQMDRSSAQVVAEML 719
Cdd:pfam09127  92 TFEKNKDFYHPICRAMVEKDL 112
M1_LTA4H cd09599
Peptidase M1 family including Leukotriene A4 hydrolase catalytic domain; This model represents ...
244-553 5.74e-21

Peptidase M1 family including Leukotriene A4 hydrolase catalytic domain; This model represents the N-terminal catalytic domain of leukotriene A4 hydrolase (LTA4H; E.C. 3.3.2.6) and the close homolog cold-active aminopeptidase (Colwellia psychrerythraea-type peptidase; ColAP), both members of the aminopeptidase M1 family. LTA4H is a bifunctional enzyme, possessing an aminopeptidase as well as an epoxide hydrolase activity. The two activities occupy different, but overlapping sites. The activity and physiological relevance of the aminopeptidase is poorly understood while the epoxide hydrolase converts leukotriene A4 (LTA4) into leukotriene B4 (LTB4), a potent chemotaxin that is fundamental to the inflammatory response of mammals. It accepts a variety of substrates, including some opioid, di- and tripeptides, as well as chromogenic aminoacyl-p-nitroanilide derivatives. The aminopeptidase activity of LTA4H is possibly involved in the processing of peptides related to inflammation and host defense. Kinetic analysis shows that LTA4H hydrolyzes arginyl tripeptides with high efficiency and specificity, indicating its function as an arginyl aminopeptidase. Thermodynamic characterization using different biophysical methods shows that structurally distinct inhibitors of the LTA4H occupy different regions of the binding site; while some (RB202, ARM1 and SC57461A) bind to the hydrophobic hydrolase side, both bestatin and captopril are located at the hydrophilic peptidase side. LTB4H overexpression is associated with different pathological conditions and diseases such as cystic fibrosis, coronary heart disease, sepsis, shock, connective tissue disease, and chronic obstructive pulmonary disease. It is also overexpressed in certain human cancers, and has been identified as a functionally important target for mediating anticancer properties of resveratrol, a well-known red wine polyphenolic compound with cancer chemopreventive activity.


Pssm-ID: 341062 [Multi-domain]  Cd Length: 442  Bit Score: 96.37  E-value: 5.74e-21
                          10        20        30        40        50        60        70        80
                  ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1034671665 244 IRIWYKTKPEGRSVTW-----TSDQSgRPCVYTVGSPINNRALFPCQEPPVAMSTWQATVRAAASFVVLMSGENSAKPtq 318
Cdd:cd09599    98 VKIEYSTTPQATALQWltpeqTAGKK-HPYLFTQCQAIHARSLFPCQDTPSVKSTYSATVTVPKGLTALMSALRTGEK-- 174
                          90       100       110       120       130       140       150       160
                  ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1034671665 319 lwEECSSWYYYVTM--PMPASTFTIAVGcwtemkmetwssnDLAtERPFSPseanfrHVGVCShmEypcrfqnasattqe 396
Cdd:cd09599   175 --EEAGTGTYTFEQpvPIPSYLIAIAVG-------------DLE-SREIGP------RSGVWA--E-------------- 216
                         170       180       190       200       210       220       230       240
                  ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1034671665 397 iiPHRVfapvcltgACQETLLRLIPPCLSAAHSVLGAHPFSRLDVLIVPANFPSLGMARP----------SKDKtghtsd 466
Cdd:cd09599   217 --PSVV--------DAAAEEFADTEKFLKAAEKLYGPYVWGRYDLLVLPPSFPYGGMENPcltfatptliAGDR------ 280
                         250       260       270       280       290       300       310       320
                  ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1034671665 467 SGASVIKH------------------------------------------------------------------------ 474
Cdd:cd09599   281 SLVDVIAHeiahswsgnlvtnanwehfwlnegftvylerrilerlygeeyrqfeailgwkdlqesikefgedppytllvp 360
                         330       340       350       360       370       380       390       400
                  ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1034671665 475 ---GLNPEKIFMQVHYLKGYFLLRFLAKRLGDETYFSFLRKFVHTFHGQLILSQDFLQMLLENIPEEKRLELSVENIyQD 551
Cdd:cd09599   361 dlkGVDPDDAFSSVPYEKGFQFLYYLEQLGGREVFDPFLRAYFKKFAFQSIDTEDFKDFLLEYFAEDKPEILDKIDW-DA 439

                  ..
gi 1034671665 552 WL 553
Cdd:cd09599   440 WL 441
PepN COG0308
Aminopeptidase N, contains DUF3458 domain [Amino acid transport and metabolism];
217-560 1.70e-14

Aminopeptidase N, contains DUF3458 domain [Amino acid transport and metabolism];


Pssm-ID: 440077 [Multi-domain]  Cd Length: 609  Bit Score: 76.99  E-value: 1.70e-14
                          10        20        30        40        50        60        70        80
                  ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1034671665 217 ELLFDTDTWSLQIRKTGAQTATDfPHAIRIWYKTKPEGRSVTW---TSDQSGRPCVYTVGSPINNRALFPCQEPPVAMST 293
Cdd:COG0308    69 PLDFTRDGERLTITLPKPLAPGE-TFTLEIEYSGKPSNGGEGLyrsGDPPDGPPYLYTQCEPEGARRWFPCFDHPDDKAT 147
                          90       100       110       120       130       140       150       160
                  ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1034671665 294 WQATVRAAASFVVLMSGeNSAKPTQLWEECSSWYYYVTMPMPASTFTIAVGcwtemkmetwssndlaterpfspseanfr 373
Cdd:COG0308   148 FTLTVTVPAGWVAVSNG-NLVSETELGDGRTTWHWADTQPIPTYLFALAAG----------------------------- 197
                         170       180       190       200       210       220       230       240
                  ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1034671665 374 hvgvcshmeypcRFQNASATTQEIIPHRVFAPVCLTGACQETLLRLiPPCLSAAHSVLG-AHPFSRLDVLIVPaNFPSLG 452
Cdd:COG0308   198 ------------DYAVVEDTFASGVPLRVYVRPGLADKAKEAFEST-KRMLDFFEELFGvPYPFDKYDQVAVP-DFNFGA 263
                         250       260       270       280       290       300       310       320
                  ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1034671665 453 M-------------ARP-------------------------------------------------SKDKTGHT------ 464
Cdd:COG0308   264 MenqglvtfgekvlADEtatdadyerresviahelahqwfgnlvtcadwddlwlnegfatymeqlfSEDLYGKDaadrif 343
                         330       340       350       360       370       380       390       400
                  ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1034671665 465 ----------SDSGAS----VIKHGLNPEKIFMQVHYLKGYFLLRFLAKRLGDETYFSFLRKFVHTFHGQLILSQDFLQM 530
Cdd:COG0308   344 vgalrsyafaEDAGPNahpiRPDDYPEIENFFDGIVYEKGALVLHMLRTLLGDEAFRAGLRLYFARHAGGNATTEDFLAA 423
                         410       420       430
                  ....*....|....*....|....*....|
gi 1034671665 531 LlenipeEKRLELSVENIYQDWLESSGIPK 560
Cdd:COG0308   424 L------EEASGRDLSAFFDQWLYQAGLPT 447
leuko_A4_hydro TIGR02411
leukotriene A-4 hydrolase/aminopeptidase; Members of this family represent a distinctive ...
244-707 4.06e-11

leukotriene A-4 hydrolase/aminopeptidase; Members of this family represent a distinctive subset within the zinc metallopeptidase family M1 (pfam01433). The majority of the members of pfam01433 are aminopeptidases, but the sequences in this family for which the function is known are leukotriene A-4 hydrolase. A dual epoxide hydrolase and aminopeptidase activity at the same active site is indicated. The physiological substrate for aminopeptidase activity is not known.


Pssm-ID: 274120 [Multi-domain]  Cd Length: 602  Bit Score: 66.34  E-value: 4.06e-11
                          10        20        30        40        50        60        70        80
                  ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1034671665 244 IRIWYKTKPEGRSVTW-TSDQ-SGR--PCVYTVGSPINNRALFPCQEPPVAMSTWQATVRaaASFVVLMSGENSAKPTql 319
Cdd:TIGR02411  97 LNISFSTTPKCTALQWlNPEQtSGKkhPYLFSQCQAIHARSLFPCQDTPSVKSTYTAEVE--SPLPVLMSGIRDGETS-- 172
                          90       100       110       120       130       140       150       160
                  ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1034671665 320 wEECSSWYYYVTMPMPASTFTIAVGcwtemkmetwssnDLATeRPFSPseanfrhvgvcshmeypcrfqNASATTQEIIP 399
Cdd:TIGR02411 173 -NDPGKYLFKQKVPIPAYLIAIASG-------------DLAS-APIGP---------------------RSTVYSEPEQL 216
                         170       180       190       200       210       220       230       240
                  ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1034671665 400 HrvfapvcltgACQETLLRLIPPCLSAAHSVLGAHPFSRLDVLIVPANFPSLGMARP----------SKDKtghtsdSGA 469
Cdd:TIGR02411 217 E----------KCQYEFENDTEKFIKTAEDLIFPYEWGQYDLLVLPPSFPYGGMENPnltfatptliAGDR------SNV 280
                         250       260       270       280       290       300       310       320
                  ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1034671665 470 SVIKHGL------------------------------------------------------------------------- 476
Cdd:TIGR02411 281 DVIAHELahswsgnlvtncswehfwlnegwtvylerriigrlygektrhfsaligwgdlqesvktlgetpeftklvvdlk 360
                         330       340       350       360       370       380       390       400
                  ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1034671665 477 --NPEKIFMQVHYLKGYFLLRFLAKRLGDETYFS-FLRKFVHTFHGQLILSQDFLQMLLENIPEEKRLELSVENIYQDWL 553
Cdd:TIGR02411 361 dnDPDDAFSSVPYEKGFNFLFYLEQLLGGPAEFDpFLRHYFKKFAYKSLDTYQFKDALYEYFKDKKKVDKLDAVDWETWL 440
                         410       420       430       440       450       460       470       480
                  ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1034671665 554 ESSGIP--KPlqrerraGAECGLARQVRAEVTKWIGVNRRPRKRK-RREKEEVFEKLLPDQLVLLLEHLLEQKTLSPRTL 630
Cdd:TIGR02411 441 YSPGMPpvKP-------NFDTTLADECYALADRWVDAAKADDLSSfNAKDIKDFSSHQLVLFLETLTERGGDWALPEGHI 513
                         490       500       510       520       530       540       550       560
                  ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1034671665 631 QSLQRTYHL-QDQDAEVRHRWCELIVKHKFTKAYKSVERFLQEDQAMGVY--LYGELMVSEDARQqqlARRCFERTKEQM 707
Cdd:TIGR02411 514 KRLGDIYNFaASKNAEVRFRWFRLAIQAKLEDEYPLLADWLGTVGRMKFVrpGYRLLNAFVDRDL---AIRTFEKFKDSY 590
Peptidase_M1 pfam01433
Peptidase family M1 domain; Members of this family are aminopeptidases. The members differ ...
450-533 3.76e-04

Peptidase family M1 domain; Members of this family are aminopeptidases. The members differ widely in specificity, hydrolysing acidic, basic or neutral N-terminal residues. This family includes leukotriene-A4 hydrolase, this enzyme also has an aminopeptidase activity.


Pssm-ID: 426262 [Multi-domain]  Cd Length: 219  Bit Score: 42.66  E-value: 3.76e-04
                          10        20        30        40        50        60        70        80
                  ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1034671665 450 SLGMARPSKDKTGHTSDsgasvikhglnPEKIFMQVHYLKGYFLLRFLAKRLGDETYFSFLRKFVHTFHGQLILSQDFLQ 529
Cdd:pfam01433 133 ALDSSHPITQNVNDPSE-----------IDDIFDAIPYEKGASVLRMLETLLGEEVFQKGLRSYLKKFQYGNATTEDLWD 201

                  ....
gi 1034671665 530 MLLE 533
Cdd:pfam01433 202 ALSE 205
M1_APN_like cd09604
Peptidase M1 family similar to aminopeptidase N catalytic domain; This family contains ...
487-553 7.90e-04

Peptidase M1 family similar to aminopeptidase N catalytic domain; This family contains bacterial M1 peptidases with smilarity to the catalytic domain of aminopeptidase N (APN; CD13; alanyl aminopeptidase; EC 3.4.11.2), a type II integral membrane protease belonging to the M1 gluzincin family. APN preferentially cleaves neutral amino acids from the N-terminus of oligopeptides and, in higher eukaryotes, is present in a variety of human tissues and cell types (leukocyte, fibroblast, endothelial and epithelial cells). APN expression is dysregulated in inflammatory diseases such as chronic pain, rheumatoid arthritis, multiple sclerosis, systemic sclerosis, systemic lupus erythematosus, polymyositis/dermatomyosytis and pulmonary sarcoidosis, and is enhanced in tumor cells such as melanoma, renal, prostate, pancreas, colon, gastric and thyroid cancers. It is predominantly expressed on stem cells and on cells of the granulocytic and monocytic lineages at distinct stages of differentiation, thus considered a marker of differentiation. Thus, APN inhibition may lead to the development of anti-cancer and anti-inflammatory drugs. APNs are also present in many pathogenic bacteria and represent potential drug targets. Some APNs have been used commercially, such as one from Lactococcus lactis used in the food industry. APN also serves as a receptor for coronaviruses, although the virus receptor interaction site seems to be distinct from the enzymatic site and aminopeptidase activity is not necessary for viral infection. APNs have also been extensively studied as putative Cry toxin receptors. Cry1 proteins are pore-forming toxins that bind to the midgut epithelial cell membrane of susceptible insect larvae, causing extensive damage. Several different toxins, including Cry1Aa, Cry1Ab, Cry1Ac, Cry1Ba, Cry1Ca and Cry1Fa, have been shown to bind to APNs; however, a direct role of APN in cytotoxicity has been yet to be firmly established.


Pssm-ID: 341067 [Multi-domain]  Cd Length: 440  Bit Score: 42.65  E-value: 7.90e-04
                          10        20        30        40        50        60
                  ....*....|....*....|....*....|....*....|....*....|....*....|....*..
gi 1034671665 487 YLKGYFLLRFLAKRLGDETYFSFLRKFVHTFHGQLILSQDFLQMLlenipeEKRLELSVENIYQDWL 553
Cdd:cd09604   380 YSKGALFLEELREELGDEAFDKALREYYRRYKFKHPTPEDFFRTA------EEVSGKDLDWFFRGWL 440
 
Blast search parameters
Data Source: Precalculated data, version = cdd.v.3.21
Preset Options:Database: CDSEARCH/cdd   Low complexity filter: no  Composition Based Adjustment: yes   E-value threshold: 0.01

References:

  • Wang J et al. (2023), "The conserved domain database in 2023", Nucleic Acids Res.51(D)384-8.
  • Lu S et al. (2020), "The conserved domain database in 2020", Nucleic Acids Res.48(D)265-8.
  • Marchler-Bauer A et al. (2017), "CDD/SPARCLE: functional classification of proteins via subfamily domain architectures.", Nucleic Acids Res.45(D)200-3.
Help | Disclaimer | Write to the Help Desk
NCBI | NLM | NIH